Pembrolizumab monotherapy for advanced chordoma – Authors' reply

Jean Yves Blay, Nicolas Penel, Florence Duffaud, Emmanuelle Bompas, Christophe Massard, Sylvie Chevret

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{ae399446cd884be080fdf938a903493e,

title = "Pembrolizumab monotherapy for advanced chordoma – Authors' reply",

author = "Blay, {Jean Yves} and Nicolas Penel and Florence Duffaud and Emmanuelle Bompas and Christophe Massard and Sylvie Chevret",

year = "2023",

month = oct,

day = "1",

doi = "10.1016/S1470-2045(23)00454-0",

language = "English",

volume = "24",

pages = "e400",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "10",

}

TY - JOUR

T1 - Pembrolizumab monotherapy for advanced chordoma – Authors' reply

AU - Blay, Jean Yves

AU - Penel, Nicolas

AU - Duffaud, Florence

AU - Bompas, Emmanuelle

AU - Massard, Christophe

AU - Chevret, Sylvie

PY - 2023/10/1

Y1 - 2023/10/1

UR - http://www.scopus.com/inward/record.url?scp=85172685112&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(23)00454-0

DO - 10.1016/S1470-2045(23)00454-0

M3 - Letter

C2 - 37797638

AN - SCOPUS:85172685112

SN - 1470-2045

VL - 24

SP - e400

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -